US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by eXoZymes

News headline image
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ
News headline image
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ
News headline image
eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ
News headline image
eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ
News headline image
eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ
News headline image
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ
News headline image
eXoZymes Inc. Announces Closing of $6 Million Public Offering
From eXoZymes
Via ACCESS Newswire
Tickers EXOZ